DESIGN AND EVALUATION OF A FIXED DOSE COMBINATION FORMULATION OF VALSARTAN AND METFORMIN HCl FOR BIPHASIC DRUG RELEASE: A NOVEL APPROACH TO INCREASE THERAPEUTIC EFFICACY
Journal Title: International Journal of Pharmaceutical Science and Technology - Year 2011, Vol 6, Issue 1
Abstract
The objective of the present study is to formulate a fixed dose combined drug formulation of valsartan (VAL) as an immediate release layer and metformin HCl (MHCl) as a sustained release form using bilayer tablet technology, which enables biphasic drug release for once daily dosing to get a better therapeutic efficacy. The immediate release layer was prepared using super disintegrant crospovidone and extended release layer using hydroxypropylmethylcellulose (HPMC K100M), sodium carboxy methyl cellulose and povidone K90. The physicochemical compatibility and stability of the tablets were determined by Fourier transform infrared spectroscopy (FTIR), X-ray diffractometry (XRD) and differential scanning calorimetry (DSC). Bilayer tablets were subjected to accelerated stability studies for 6 months. The in-vitro release studies indicate that bi-layer tablets effectively control the drug release. Bilayer tablets were evaluated for hardness, friability, weight variation, thickness, and drug content uniformity and subjected to in vitro drug release studies using different kinetic models. The amount of VAL and MHCl released at different time intervals were estimated by HPLC method. FTIR, XRD and DSC data for the formulations indicate good compatibility and stability. These tablets exhibit no significant change either in physical appearance or dissolution pattern after storage at accelerated condition (40±2°C / 75±5%RH) for 6 months. The results indicated that VAL and MHCl could be a potential fixed dose combination form for the simultaneous treatment of hypertension and diabetes and can be developed into suitable bilayer tablets.
Authors and Affiliations
Subas C. Dinda , Durga P. Pattanayak , Ulna L. Narayan
Keywords
Related Articles
- EP ID EP150806
- DOI -
- Views 103
- Downloads 0
SOLUBILITY PROFILES OF SELECTED DRUGS IN EDIBLE OIL MEDIA
The solubility of selected drugs in edible oils was determined to promote development of edible oil based dosage forms and to initiate an oil solubility data base. Aqueous based formulations are open to hydrolytic, oxi...
SCREENING STRATEGY FOR HIGH THROUGHPUT SELECTION OF NITRILASE PRODUCING MICROORGANISMS AND MUTANTS FOR THE PRODUCTION OF PHARMACEUTICALLY IMPORTANT DRUGS AND DRUG INTERME
The prerequisite for fully exploiting the potential of a particular biocatalyst and for the laboratory evolution studies is the requirement of a reliable and convenient high throughput screening method. The major hurdle...
COMPARATIVE STUDY ON VARIOUS TABLETING PROPERTIES OF PHENYTOIN SODIUM MOUTH DISSOLVING DOSAGE FORM WITH AND WIT HOUT SPHERICAL CRYSTALS
The aim of the present research is to advance the engineering of pharmaceutical agglomerates, for the purpose of tailoring the properties by modulation of processing parameters like solvent composition, hydrodynamics, a...
An in vitro evaluation of a guar gum matrix formulation targeting colon, using ibuprofen as a model drug
The concentration of a drug in the blood fluctuates over successive administrations of conventional single unit dosage forms. The main reason for this is because conventional dosage forms are designed to release the co...
In vivo evaluation and the stability study of the formulation “Denticap” intended for local application to relieve dental pain
Lidocaine is widely used in toothache, teething, to relieve pain or irritation caused by dentures or other dental appliances, including braces. Most of the available dental formulations are liquid and last only few hours...